Nifty

:

17799.10

Sensex

:

60086.01

136.95 (0.78%)
536.11 (0.90%)

Login

Nifty
Sensex

:
:

17799.10
60086.01

136.95 (0.78%)
536.11 (0.90%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

41/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

213.34
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

356.34
N/A
-2.44

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
12.06
21.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
35.25
12.83

PAT CAGR (%)

10 Years
5 Years
3 Years

-
20.10
15.54

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-6.52
-6.52
-6.52

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-17.59
-22.77
-15.27

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 20.94 11.98 74.79% 10.64 6.75 57.63% 19.16 15.86 20.81% 21.81 9.58 127.66%
Expenses 22.84 19.77 15.53% 16.91 13.28 27.33% 28.94 20.38 42.00% 31.71 15.23 108.21%
EBITDA -1.90 -7.79 - -6.27 -6.53 - -9.78 -4.53 - -9.90 -5.65 -
EBIDTM -9.08% -65.02% -58.90% -96.61% -51.04% -28.53% -45.41% -59.00%
Other Income 0.28 0.13 115.38% 0.13 0.03 333.33% 0.79 0.44 79.55% 0.20 0.06 233.33%
Interest 0.74 1.78 -58.43% 0.30 1.51 -80.13% 0.28 1.49 -81.21% 1.82 1.43 27.27%
Depreciation 1.69 1.42 19.01% 1.69 1.42 19.01% 2.05 1.41 45.39% 1.42 1.24 14.52%
PBT -4.06 -10.85 - -8.14 -9.42 - -11.31 -6.99 - -12.94 -8.26 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -4.06 -10.85 - -8.14 -9.42 - -11.31 -6.99 - -12.94 -8.26 -
PATM -19.40% -90.56% -76.46% -139.51% -59.06% -44.06% -59.34% -86.25%
EPS -1.88 -5.02 - -3.77 -4.36 - -5.24 -3.23 - -5.99 -3.82 -

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13
Net Sales 72.55 59.70 53.70 33.41 47.76 33.78 3.53 1.29 0.00 0.00 11.45 Net Sales Growth 64.25% 11.17% 60.73% -30.05% 41.39% 856.94% 173.64% 0 0 -100% Cost Of Goods Sold 50.64 40.64 25.94 15.86 23.10 12.67 1.20 0.14 0.00 0.00 4.61 Gross Profit 21.91 19.06 27.75 17.55 24.65 21.10 2.33 1.14 0.00 0.00 6.83 GP Margin 30.20% 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% 88.37% 0 0 59.65% Total Expenditure 100.40 93.64 71.28 51.97 57.52 41.28 11.53 13.69 4.90 4.04 24.63 Power & Fuel Cost - 22.79 15.91 10.28 11.70 8.62 0.70 2.87 0.28 1.87 6.24 % Of Sales - 38.17% 29.63% 30.77% 24.50% 25.52% 19.83% 222.48% 0 0 54.50% Employee Cost - 14.93 15.30 14.56 14.41 11.49 5.63 5.67 1.86 0.55 9.08 % Of Sales - 25.01% 28.49% 43.58% 30.17% 34.01% 159.49% 439.53% 0 0 79.30% Manufacturing Exp. - 10.27 10.37 6.77 4.09 4.59 1.07 1.62 0.62 0.04 1.76 % Of Sales - 17.20% 19.31% 20.26% 8.56% 13.59% 30.31% 125.58% 0 0 15.37% General & Admin Exp. - 4.60 3.47 4.05 4.05 3.76 2.88 3.33 2.14 1.54 2.57 % Of Sales - 7.71% 6.46% 12.12% 8.48% 11.13% 81.59% 258.14% 0 0 22.45% Selling & Distn. Exp. - 0.23 0.14 0.16 0.13 0.13 0.05 0.04 0.00 0.01 0.29 % Of Sales - 0.39% 0.26% 0.48% 0.27% 0.38% 1.42% 3.10% 0 0 2.53% Miscellaneous Exp. - 0.18 0.13 0.29 0.02 0.02 0.01 0.02 0.00 0.03 0.29 % Of Sales - 0.30% 0.24% 0.87% 0.04% 0.06% 0.28% 1.55% 0 0 0.52% EBITDA -27.85 -33.94 -17.58 -18.56 -9.76 -7.50 -8.00 -12.40 -4.90 -4.04 -13.18 EBITDA Margin -38.39% -56.85% -32.74% -55.55% -20.44% -22.20% -226.63% -961.24% 0 0 -115.11% Other Income 1.40 1.16 0.62 0.37 0.33 0.21 0.08 1.03 0.01 0.18 6.14 Interest 3.14 5.45 6.28 6.00 6.29 5.17 3.49 0.74 4.03 0.08 0.63 Depreciation 6.85 6.30 5.12 4.68 4.40 4.15 4.23 4.49 1.87 0.00 8.28 PBT -36.45 -44.53 -28.36 -28.87 -20.12 -16.61 -15.65 -16.60 -10.79 -3.95 -15.94 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.74 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.13% 4.64% PAT -36.45 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 PAT before Minority Interest -36.45 -44.53 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -50.24% -74.59% -52.81% -86.41% -41.90% -52.75% -454.67% -1265.12% 0 0 -132.75% PAT Growth 0.00% - - - - - - - - - EPS -16.88 -20.62 -13.13 -13.37 -9.26 -8.25 -7.43 -7.56 -3.63 -2.01 -7.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13
Shareholder's Funds -75.09 -42.73 -25.00 -14.29 -17.78 1.48 13.01 18.28 3.60 7.95 Share Capital 21.56 19.62 18.00 16.63 13.74 13.74 13.06 9.51 9.51 9.51 Total Reserves -96.65 -66.52 -50.65 -30.92 -31.52 -12.27 -3.72 -14.08 -5.91 -1.57 Non-Current Liabilities 186.83 153.76 115.66 101.79 101.37 88.88 73.88 60.12 23.02 57.33 Secured Loans 0.00 0.00 0.00 0.00 1.89 5.03 21.40 14.00 15.00 48.70 Unsecured Loans 132.93 100.55 65.51 50.23 49.78 37.76 3.91 43.61 7.32 8.35 Long Term Provisions 2.63 2.56 2.46 4.04 3.68 2.82 3.57 3.83 2.02 2.00 Current Liabilities 78.06 48.19 43.13 54.86 42.28 31.72 29.52 28.72 109.84 70.64 Trade Payables 37.91 20.78 22.65 21.44 17.76 10.99 12.37 16.54 19.79 19.75 Other Current Liabilities 29.01 15.92 18.50 32.00 23.27 19.86 16.34 12.09 84.67 31.92 Short Term Borrowings 9.99 10.00 0.00 0.00 0.00 0.00 0.00 0.00 3.48 18.73 Short Term Provisions 1.17 1.49 1.99 1.43 1.25 0.87 0.82 0.09 1.90 0.24 Total Liabilities 189.80 159.22 133.79 142.36 125.87 122.08 116.41 107.12 136.46 135.92 Net Block 138.71 117.93 105.29 101.27 100.77 102.17 93.10 50.98 50.58 50.63 Gross Block 287.95 260.88 243.11 234.41 229.51 226.55 213.24 166.84 164.25 164.31 Accumulated Depreciation 149.25 142.95 137.82 133.15 128.74 124.38 120.14 115.86 113.66 113.67 Non Current Assets 154.31 137.80 114.94 111.39 108.64 109.10 107.03 92.26 97.66 97.49 Capital Work in Progress 8.38 11.94 4.19 3.48 3.73 3.50 10.54 7.46 7.13 7.13 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.00 7.71 5.24 6.22 3.72 3.23 3.19 33.82 39.95 39.73 Other Non Current Assets 0.22 0.23 0.21 0.42 0.41 0.20 0.20 0.00 0.00 0.00 Current Assets 35.49 21.42 18.86 30.98 17.24 12.97 9.39 14.87 38.81 38.43 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 25.56 16.60 15.00 8.96 11.73 5.45 5.64 5.45 30.82 30.82 Sundry Debtors 0.88 0.30 0.20 2.91 0.32 1.59 0.03 0.37 0.62 0.92 Cash & Bank 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 Other Current Assets 8.95 0.47 0.31 0.21 4.77 5.81 3.46 2.74 7.01 6.35 Short Term Loans & Adv. 8.36 3.33 3.18 1.57 4.44 5.67 3.38 0.59 5.41 4.91 Net Current Assets -42.57 -26.77 -24.27 -23.88 -25.04 -18.74 -20.14 -13.86 -71.03 -32.21 Total Assets 189.80 159.22 133.80 142.37 125.88 122.07 116.42 107.13 136.47 135.92

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13
Cash From Operating Activity -17.22 -14.57 -35.50 3.90 -6.19 -11.20 -15.26 -45.26 49.24 -1.55 PBT -44.53 -28.36 -28.87 -20.12 -16.61 -16.05 -16.60 -10.79 -4.10 -15.94 Adjustment 11.41 11.68 8.95 10.31 6.46 10.67 3.45 8.84 0.22 2.76 Changes in Working Capital 15.90 2.11 -15.58 13.71 9.12 -2.33 -1.38 -39.28 54.65 12.37 Cash after chg. in Working capital -17.22 -14.57 -35.50 3.90 -1.02 -7.71 -14.53 -41.23 50.76 -0.81 Interest Paid 0.00 0.00 0.00 0.00 -5.17 -3.49 -0.74 -4.03 -1.53 -0.63 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -22.90 -22.55 -10.22 -4.32 -2.77 -4.70 -4.00 -2.92 0.07 5.54 Net Fixed Assets -23.51 -25.52 -9.41 -4.65 -3.19 -6.27 -49.48 -2.92 0.06 -0.61 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.61 2.97 -0.81 0.33 0.42 1.57 45.48 0.00 0.01 6.15 Cash from Financing Activity 39.51 37.66 28.58 17.32 9.26 15.75 13.22 54.13 -49.28 -4.09 Net Cash Inflow / Outflow -0.61 0.54 -17.14 16.90 0.30 -0.15 -6.04 5.95 0.03 -0.10 Opening Cash & Equivalents 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 Closing Cash & Equivalent 0.10 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13
Book Value (Rs.) -34.83 -23.91 -18.14 -8.59 -12.49 1.04 6.91 -4.63 3.66 8.07 ROA -25.51% -19.36% -20.91% -14.92% -14.38% -13.46% -14.60% -6.44% -3.19% -10.72% ROE 0.00% 0.00% 0.00% 0.00% 0.00% -296.70% -683.34% 0.00% -75.26% -97.77% ROCE -57.29% -40.28% -56.96% -35.41% -28.95% -27.13% -25.38% -4.33% -3.91% -14.60% Fixed Asset Turnover 0.22 0.21 0.14 0.21 0.15 0.02 0.01 0.00 0.00 0.07 Receivable days 3.60 1.71 17.00 12.36 10.34 83.55 51.87 0.00 0.00 130.58 Inventory Days 128.88 107.38 130.87 79.07 92.84 573.34 1435.63 0.00 0.00 925.22 Payable days 263.51 305.42 148.85 123.16 120.44 290.43 338.13 1500.06 2505.25 277.77 Cash Conversion Cycle -131.03 -196.34 -0.98 -31.73 -17.27 366.46 1149.37 -1500.06 -2505.25 778.03 Total Debt/Equity -1.91 -2.37 -2.03 -3.74 -3.16 32.19 3.27 -13.34 25.86 11.65 Interest Cover -7.17 -3.52 -3.81 -2.18 -2.45 -3.60 -21.09 -0.95 -45.92 -24.33

Top Investors:

sun pharmaceutical industries ltd

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
10th Nov 2022, 16:14 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback